SCHEMBL1030372

SCHEMBL1030372

CC(C)Oc1cccc(-c2nc(N)ncc2C2CCCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.46
▸ ADORA2A P29274 3/20 0.46
▸ ADORA1 P30542 2/20 0.46
▸ ALOX5AP P20292 1/20 0.43
▸ FEN1 P39748 1/20 0.43
▸ HRH2 P25021 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.43
▸ MAP4K4 O95819 1/20 0.42
▸ GABRA1 P14867 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41
▸ GABRA5 P31644 1/20 0.41
▸ GABRA3 P34903 1/20 0.41
▸ WDR5 P61964 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ IGF1R P08069 4/20 0.39
▸ TGFBR1 P36897 1/20 0.38
▸ ACVR1 Q04771 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618779 0.86 ADORA2A (0.59) ADORA2AADORA1ALOX5APFEN1HRH2
SCHEMBL1033184 0.81 DHFR (0.45) DHFRADORA2AADORA1ALOX5APFEN1
SCHEMBL3620507 0.71 TNK2 (0.47) DHFRFEN1HRH3
SCHEMBL2409415 0.68 DHODH (0.53) DHFRMAP4K4GABRA1GABRG2GABRB3
SCHEMBL6134331 0.68 ADORA1 (0.45) DHFRADORA2AADORA1MAP4K4GABRA1
SCHEMBL12137691 0.67 MAP4K4 (0.45) DHFRADORA2AADORA1MAP4K4GABRA1
SCHEMBL30788667 0.65 RXRA (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL26188309 0.65 ALDH1A1 (0.59) RXRARXRB
SCHEMBL8469211 0.65 RXRA (0.72) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL22831324 0.64 MAP4K4 (0.50) DHFRMAP4K4GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 — — WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 — — WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 — — WO disclosed
Send feedback